View in EDS HTML Full Text PDF Full Text

Liquid biopsy‐based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.

Saved in:
Bibliographic Details
Title: Liquid biopsy‐based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Authors: Mata, Douglas A1 (AUTHOR), Lee, Jessica K1 (AUTHOR), Shanmugam, Vignesh2,3 (AUTHOR), Marcus, Chelsea B1 (AUTHOR), Schrock, Alexa B1 (AUTHOR), Williams, Erik A1,4 (AUTHOR), Ritterhouse, Lauren L1 (AUTHOR), Hickman, Richard A1 (AUTHOR), Janovitz, Tyler1 (AUTHOR), Patel, Nimesh R5 (AUTHOR), Kroger, Benjamin R6 (AUTHOR), Ross, Jeffrey S1,7 (AUTHOR), Mirza, Kamran M8 (AUTHOR), Oxnard, Geoffrey R1 (AUTHOR), Vergilio, Jo‐Anne1 (AUTHOR), Elvin, Julia A1 (AUTHOR), Benhamida, Jamal K9 (AUTHOR), Decker, Brennan1 (AUTHOR), Xu, Mina L10 (AUTHOR) mina.xu@yale.edu
Source: Histopathology. Jun2024, Vol. 84 Issue 7, p1224-1237. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:03090167
DOI:10.1111/his.15168